Screening for TP53 rearrangements in families with the Li–Fraumeni syndrome reveals a complete deletion of the TP53 gene

被引:0
|
作者
Gaëlle Bougeard
Laurence Brugières
Agnès Chompret
Paul Gesta
Françoise Charbonnier
Alexander Valent
Cosette Martin
Grégory Raux
Jean Feunteun
Brigitte Bressac-de Paillerets
Thierry Frébourg
机构
[1] Inserm EMI 9906 – IFRMP,Department of Pediatrics
[2] Faculty of Medicine,Department of Genetics
[3] Institut Gustave Roussy,Department of Cellular Genomics of Cancers
[4] Oncology,Department of Clinical Biology
[5] Centre Hospitalier,undefined
[6] CHU of Rouen,undefined
[7] Institut Gustave Roussy,undefined
[8] UMR 8125,undefined
[9] Institut Gustave Roussy,undefined
[10] Institut Gustave Roussy,undefined
来源
Oncogene | 2003年 / 22卷
关键词
Li–Fraumeni syndrome; deletion; PCR;
D O I
暂无
中图分类号
学科分类号
摘要
The absence of detectable germline TP53 mutations in a fraction of families with Li–Fraumeni syndrome (LFS) has suggested the involvement of other genes, but this hypothesis remains controversial. The density of Alu repeats within the TP53 gene led us to search genomic rearrangements of TP53 in families without detectable TP53 mutation. To this aim, we adapted the quantitative multiplex PCR of short fluorescent fragments (QMPSF) method to the analysis of the 11 exons of TP53. We analysed 98 families, either fulfilling (six families) or partially meeting (92 families) the criteria for LFS, and in which classical methods had failed to reveal TP53 alterations. We identified, in a large family fulfilling the criteria for LFS, a complete heterozygous deletion of TP53. Additional QMPSF analyses indicated that this deletion, which partially removed the centromeric FLJ10385 locus, covered approximately 45 kb. This deletion was shown to result from a complex rearrangement involving two distinct Alu-mediated recombinations. We conclude that TP53 germline rearrangements occur as rare events, but must be considered in LFS families without detectable point TP53 mutation.
引用
收藏
页码:840 / 846
页数:6
相关论文
共 50 条
  • [41] TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes
    Andrade, Raissa Coelho
    Evangelista dos Santos, Anna Claudia
    de Aguirre Neto, Joaquim Caetano
    Nevado, Julian
    Lapunzina, Pablo
    Vargas, Fernando Regla
    FAMILIAL CANCER, 2017, 16 (02) : 243 - 248
  • [42] Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
    Burt, E. C.
    James, L. A.
    Greaves, M. J.
    Birch, J. M.
    Boyle, J. M.
    Varley, J. M.
    BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 467 - 472
  • [43] Germline copy number variation in Li-Fraumeni syndrome patients with TP53 mutations
    Silva, Amanda G. S.
    Achatz, Maria Isabel W.
    Brentani, Ricardo
    Krepischi, Ana Cristina V.
    Rosenberg, Carla
    CANCER RESEARCH, 2011, 71
  • [44] Malignant triton tumor in a patient with Li-fraumeni syndrome and a novel TP53 mutation
    Chao, Mwe Mwe
    Levine, John E.
    Ruiz, Robert E.
    Kohlmann, Wendy K.
    Bower, Matthew A.
    Petty, Elizabeth M.
    Mody, Rajen J.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (07) : 1000 - 1004
  • [45] A rare homozygous germline missense variant of TP53 causing Li-Fraumeni syndrome
    Chowdhury, Fuad
    Finkbeiner, Melanie
    Girgulis, Katie
    Lamont, Ryan
    Parboosingh, Jillian
    Pecheux, Lucie
    Perrier, Renee
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1264 - 1264
  • [46] Misdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic TP53 Mutation
    Mitchell, Rachel L.
    Kosche, Cory
    Burgess, Kelly
    Wadhwa, Shreya
    Buckingham, Lela
    Ghai, Ritu
    Rotmensch, Jacob
    Klapko, Oleksandra
    Usha, Lydia
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (05): : 461 - 466
  • [47] Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome
    Said, Badr Id
    Kim, Han
    Tran, James
    Novokmet, Ana
    Malkin, David
    HUMAN MUTATION, 2016, 37 (09) : 889 - 892
  • [48] Myelodysplastic Syndromes Arising in Patients With Germline TP53 Mutation and Li-Fraumeni Syndrome
    Talwalkar, Sameer S.
    Yin, C. Cameron
    Naeem, Rizwan C.
    Hicks, M. John
    Strong, Louise C.
    Abruzzo, Lynne V.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (07) : 1010 - 1015
  • [49] Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome
    Park, Kyoung-Jin
    Choi, Hyun-Jung
    Suh, Soon-Pal
    Ki, Chang-Seok
    Kim, Jong-Won
    ANNALS OF LABORATORY MEDICINE, 2016, 36 (05) : 463 - 468
  • [50] In search of TP53 mutational hot spots for Li-Fraumeni syndrome in Asian populations
    Lo Piccolo, Luca
    Jantrapirom, Salinee
    Moonmuang, Sutpirat
    Teeyakasem, Pimpisa
    Pasena, Arnat
    Suksakit, Pathacha
    Charoenkwan, Pimlak
    Pruksakorn, Dumnoensun
    Koonrungsesomboon, Nut
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2021, 26 (11) : 1401 - 1410